Genetic Testing Policy Options: Federal Agency, Expanded Oversight – Report
This article was originally published in The Gray Sheet
Executive Summary
Federal approaches to regulating pre-implantation genetic diagnosis (PGD) could entail creating a dedicated agency or giving an existing agency oversight of the procedure, a new report from the Genetics & Public Policy Center at Johns Hopkins University says
You may also be interested in...
People In Brief
Former NIH Director Bernadine P. Healy dies
People In Brief
Former NIH Director Bernadine P. Healy dies
PGD Intended Use Limitations Addressed In FDA Warning Letter
Mid-Atlantic Diagnostics says it will take steps to clarify the intended use of its Stripper micropipette, following a warning letter requiring the firm to submit a 510(k) for pre-implantation genetic diagnosis claims